Get started
Author

Kiichi Nitanai

Observed names: K. Nitanai, Nitanai, Kiichi
Observed institution: Asahikawa Medical University
ORCID: 0009-0004-8653-7593
Observed ORCID: 0009-0004-8653-7593
OpenAlex ID: A5092552992
Viability and diagnostic potential of tissues obtained through cryobiopsy
2024 · Ryotaro Kida, Ryohei Yoshida, et al. · Respiratory Investigation · 5
Sotorasib resistance in KRAS G12C-mutant invasive mucinous adenocarcinoma with implications for VEGF-A
2025 · Hiraku Yanada, Ryohei Yoshida, et al. · npj Precision Oncology · 4
PDF
Detection of resistance mutations in patients with anaplastic lymphoma kinase-rearranged lung cancer through liquid biopsy
2023 · Takaaki Sasaki, Ryohei Yoshida, et al. · Translational Lung Cancer Research · 4
PDF
Case Report: Case series: association between blood concentration and side effects of sotorasib
2023 · Ryota Shigaki, Ryohei Yoshida, et al. · Frontiers in Oncology · 2
EP.14B.08 Thymic Carcinoma with Treatment-Related Leukemia Showing Complete Response to Bcl-2 Inhibitors: A Case Report
2024 · K. Nitanai · Journal of Thoracic Oncology · 1
PDF
Monitoring SARS-CoV-2 Viral Load and CD4+ T-cell Count After ART in a Patient Diagnosed With AIDS Following SARS-CoV-2 Infection: A Case Report
2023 · Yasuhiro Umekage, Mayumi Hatayama, et al. · Cureus · 1
PDF
Thymic Carcinoma with Treatment-Related Leukemia Showing Complete Response to Bcl-2 Inhibitors and 5-azacytidine: A Case Report
2026 · Kiichi Nitanai, Takeshi Saito, et al. · JTO Clinical and Research Reports
Understanding nosocomial influenza transmission in acute-care and chronic-care wards using an agent-based model
2026 · Yasuhiro Umekage, Takashi Watanabe, et al. · Journal of Hospital Infection
PDF
LymphoQuant v1.0: source code and per-object measurements for the quantification of lymphocyte-sized cells in a patient-derived pleural effusion culture (DPP4 / EGFR-mutant NSCLC)
2026 · Nitanai, Kiichi, Yoshida, Ryohei, et al. · Zenodo (CERN European Organization for Nuclear Research)
Clinical Value of Brush Sampling for Acid-fast Bacillus Testing in Bronchoscopy: A Retrospective Study
2026 · Yasuhiro Umekage, Ayano Tanaka, et al. · Respiratory Endoscopy
Data from Dipeptidyl Peptidase 4 Restoration Facilitates Antitumor Immunity in KRAS-LKB1–Mutant Lung Cancer
2025 · Toshiyuki Tenma, Ryohei Yoshida, et al.
Figure 1 from Dipeptidyl Peptidase 4 Restoration Facilitates Antitumor Immunity in KRAS-LKB1–Mutant Lung Cancer
2025 · Toshiyuki Tenma, Ryohei Yoshida, et al.
Figure 2 from Dipeptidyl Peptidase 4 Restoration Facilitates Antitumor Immunity in KRAS-LKB1–Mutant Lung Cancer
2025 · Toshiyuki Tenma, Ryohei Yoshida, et al.
Table S1 from Dipeptidyl Peptidase 4 Restoration Facilitates Antitumor Immunity in KRAS-LKB1–Mutant Lung Cancer
2025 · Toshiyuki Tenma, Ryohei Yoshida, et al.
Figure S1 from Dipeptidyl Peptidase 4 Restoration Facilitates Antitumor Immunity in KRAS-LKB1–Mutant Lung Cancer
2025 · Toshiyuki Tenma, Ryohei Yoshida, et al.
Figure S4 from Dipeptidyl Peptidase 4 Restoration Facilitates Antitumor Immunity in KRAS-LKB1–Mutant Lung Cancer
2025 · Toshiyuki Tenma, Ryohei Yoshida, et al.
Figure 4 from Dipeptidyl Peptidase 4 Restoration Facilitates Antitumor Immunity in KRAS-LKB1–Mutant Lung Cancer
2025 · Toshiyuki Tenma, Ryohei Yoshida, et al.
Figure S3 from Dipeptidyl Peptidase 4 Restoration Facilitates Antitumor Immunity in KRAS-LKB1–Mutant Lung Cancer
2025 · Toshiyuki Tenma, Ryohei Yoshida, et al.
Figure S2 from Dipeptidyl Peptidase 4 Restoration Facilitates Antitumor Immunity in KRAS-LKB1–Mutant Lung Cancer
2025 · Toshiyuki Tenma, Ryohei Yoshida, et al.
Figure 3 from Dipeptidyl Peptidase 4 Restoration Facilitates Antitumor Immunity in KRAS-LKB1–Mutant Lung Cancer
2025 · Toshiyuki Tenma, Ryohei Yoshida, et al.
Dipeptidyl Peptidase 4 Restoration Facilitates Antitumor Immunity in KRAS-LKB1–Mutant Lung Cancer
2025 · Toshiyuki Tenma, Ryohei Yoshida, et al. · Cancer Research Communications
EP.02.04 Identification of a Novel Immunotherapy Target in EGFR-Mutant Lung Cancer Resistant to Immune Checkpoint Inhibitors
2025 · K. Nitanai · Journal of Thoracic Oncology
Treatment of lung adenocarcinoma with chemotherapy helps mitigate chronic myeloid leukaemia progression: A case report
2024 · Kazunori Nagasue, Ryotaro Kida, et al. · Oncology Letters
PDF
EP.03C.03 Development of a Novel Immunotherapy for ICI Resistant KRAS-Mutantlung Cancer
2024 · T. Tenma, K. Nitanai, et al. · Journal of Thoracic Oncology
PDF
Works count: 24
Citation count: 17
H-index: 3
I10-index:
Year
Topic
Type